A Clinical Study on the Safety and Preliminary Efficacy of IMC008 in the Treatment of CLDN18.2- Positive Advanced Solid Tumors

Study Summary

An open label, multi-center, dose-escalating study to evaluate the safety and preliminary efficacy of IMC008 in CLDN18.2 positive advanced solid tumors.

Interventions

Study Locations

Facility	City	State	Country
Shanghai Changhai Hospital	Shanghai	Shanghai Municipality	China

Official Trial Information

View on ClinicalTrials.gov